Wspolczesne metody leczenia raka gruczolu krokowego o niskim ryzyku

Abstract

Author(s): Joanna Juszczynska, Anna Brzozowska, Maria Mazurkiewicz

Prostatic cancer is a heterogeneous condition. As the screening tests are becoming increasingly available, there may be seen an increase in the incidence of early forms of prostatic cancer. The stratification of the progression risk relies on the classification proposed by d’Amico that takes into consideration the clinical stage of advancement, the level of prostate- specific antigen PSA as well as the histopathological assessment according to Gleason scale. The absence of randomized studies concerning the group of patients with a favorable profile of prostatic cancer is the source of many controversies associated with the selection of a suitable therapeutic option that would be both effective and a warranty of good quality of life for the patient. In the study herein we present contemporary methods of the treatment of persons with prostatic cancer with a low progression risk, both established ones such as surgical treatment and teleradiotherapy, and the less known such as proton therapy, stereotactic radiotherapy, cryosurgery, high-intensity focused ultrasound waves. In the discussion of respective methods, attention has been drawn to both their merits and their setbacks related to the toxicity of the treatment.

Share this article